Summary: The fiscal year 2025 (FY25) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical data sets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Major gaps to be filled by this funding opportunity include:

·        Lack of research and clinical resources, including patient tissues, cell, and tumor models.

·        Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings.

·        Lack of infrastructure for sharing data and other resources.

·        Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features:

·        Engagement and partnerships with Patient Advocates must be integrated into the project from development of the research question through the execution of the study.

·        Community building and enhancement are key components.

·        Dissemination and sustainability of the platform for scientific and/or clinical, and patient community must be described.

·        Preliminary data not required but may be included to address feasibility.

Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.

Miscellaneous

• Unrestricted